Patents
Patents for C07D 215 - Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems (27,676)
01/2009
01/29/2009US20090028858 Substituted quinoline derivatives
01/29/2009CA2694224A1 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
01/28/2009EP2018859A1 Arylmethylene substituted N-acyl-beta-amino alcohols
01/28/2009EP2018367A1 Novel microbiocides
01/28/2009EP0966443B1 Heteroaryl-hexanoic acid amide derivatives, their preparation and their use as selective inhibitors of mip-1-alpha binding to its ccr1 receptor
01/28/2009CN101356158A A new intermediate for making montelukast and related compounds
01/28/2009CN101356157A Process for making montelukast and intermediates therefor
01/28/2009CN101353447A Synthetic process of rubber antiager RD
01/28/2009CN101353324A Synthesis of enantiomerically pure amino-substituted fused bicyclic rings
01/28/2009CN101353323A Purification method of 2-methyl quinoline
01/28/2009CN100455570C Quinolinone / benzoxazinone derivatives and uses thereof
01/28/2009CN100455566C Novel derivatives of aminocyclohexane
01/27/2009US7482466 Hydroxamates as therapeutic agents
01/27/2009US7482458 Quinoline derivatives
01/27/2009US7482457 Substituted quinoline-4-carboxylic hydrazides as NK-2/NK-3 receptor ligands
01/27/2009US7482456 8-(3-Biaryl)phenylquinoline phosphodiesterase-4 inhibitors
01/27/2009US7482455 Chemical compounds
01/27/2009US7482454 Antimicrobial quinolones, their compositions, and uses
01/27/2009US7482372 Antiinflammatory; cartilage protecting therapeutics; antiarthritic agent; N-{4-[(2-methyl-4-quinolinyl)methoxy]phenyl}-2,4-dioxo-1,3-diazaspiro[4.5]decane-6-carboxamide; 2-(2,5-dioxo-4-imidazolidinyl)-N-{4-[(2-methyl-4-quinolinyl)methoxy]phenyl)acetamide
01/27/2009US7482364 Histamine H3 antagonists; do not contain imidazolyl moiety; such as 1-[4-(4-piperidin-1-ylmethyl-phenyl)-but-3-ynyl]-piperidine
01/27/2009US7482362 Substituted-4-quinolones
01/27/2009US7482346 Carboxylation of the alkylpiperazine; amidation of the carbamate-ester; cannabinoid and vanilloid receptor antagonists
01/27/2009CA2346796C Benzoylcyclohexanediones, process for their preparation and their use as herbicides and plant growth regulators
01/22/2009WO2009012283A1 Compounds and methods for kinase modulation, and indications therefor
01/22/2009WO2009011336A1 Quinoline compounds
01/22/2009WO2009010231A1 Process for the production of tertiary alcohols
01/22/2009WO2009010230A2 Process and intermediate for the production of a tertiary alcohol as an intermediate in the synthesis of montelukast
01/22/2009WO2007092157A9 7-(1h-imidazol-4-yl) methyl) -5,6,7,8-tetrahydroquinoline
01/22/2009US20090023786 Histone Deacetylase Inhibitor Prodrugs
01/22/2009US20090023774 Pyridine analogs as C5A antagonists
01/22/2009US20090023772 Novel substituted heteroaryloxy alkylamines and their use as monoamine neurotransmitter re-uptake inhibitors
01/22/2009US20090023730 such as 1-(3-tert-butyl-1-methyl-1H-pyrazole-5-carbonyl)-3-(4-(pentyloxy)-3-(trifluoromethyl)phenyl)thiourea; packages, patches; hepatitis virus infections
01/22/2009US20090023718 Diamine and Iminodiacetic Acid Hydroxamic Acid Derivatives
01/22/2009US20090023710 Compound
01/22/2009US20090023664 protease inhibitors such as 5-(dimethylamino)-N-[(2S,3R)-3-hydroxy-4-[(4-methoxyphenyl)sulfonyl-(2-methylpropyl)amino]-1-phenylbutan-2-yl]-2-methylbenzamide, used for for treating human immunodeficiency virus (HIV) infections
01/22/2009CA2695004A1 Compounds and methods for kinase modulation, and indications therefor
01/22/2009CA2692919A1 Process for the production of tertiary alcohols
01/22/2009CA2692896A1 Process and intermediate for the production of a tertiary alcohol as an intermediate in the synthesis of montelukast
01/21/2009EP2016943A1 Substituted tetrahydro-quinoline-sulfonamide compounds, their preparation and use as medicaments
01/21/2009EP1613315B1 Quinoline-2-one-derivatives for the treatment of airways diseases
01/21/2009EP1339690B1 N-type calcium channel antagonists for the treatment of pain
01/21/2009CN101348463A Synthetic method of argatroban and intermediate thereof
01/21/2009CN101348462A The purest rac-1-{4-[2-hydroxy-3-(5-quinolyloxy)propyl]piperazin-1-yl}-2,2-diphenylethan-1-one fumarate
01/21/2009CN101348455A Aspartic acid specificity cysteine proteinase inhibitors and uses thereof
01/21/2009CN100453529C Aryl sulfonamides and analogues thereof and their use in treatment of neurodegenerative diseases
01/21/2009CN100453528C Non-symmetrical gelling agent
01/20/2009US7479561 Anticarcinogenic, antiproliferative, and antitumor agents
01/20/2009US7479497 e.g. 8-hydroxy-2-[2-[3,4-dihydroxy-5-methoxyphenyl)ethenyl]]-7-quinoline carboxylic acid; HIV integrase inhibitors; AIDS, retroviral pathologies
01/20/2009US7479496 Substituted spiro azabicyclics as modulators of chemokine receptor activity
01/20/2009CA2337770C Amide derivatives which are useful as cytokine inhibitors
01/15/2009WO2008137027A3 Compounds as crth2 and/or pgd2 receptors modulators and their use for treating asthma and allergic inflammation
01/15/2009WO2008132142A3 New heterocyclic derivatives useful for the treatment of cns disorders
01/15/2009US20090018133 Novel Adamantane Derivatives
01/15/2009US20090018116 Therapeutic Compounds
01/15/2009DE102007032800A1 Nichtsteroidale Progesteronrezeptor-Modulatoren Non-steroidal progesterone receptor modulators
01/14/2009EP2014650A1 Process and intermediate for the production of an intermediate in the production of montelukast
01/14/2009EP2014633A1 Process for the production of tertiary alcohols
01/14/2009EP2014285A1 NPYY5 antagonists
01/14/2009EP2013197A1 Phenethanolamine derivatives as beta2 adrenoreceptor agonists
01/14/2009EP2013183A1 Derivatives of 4-(2-amino-1-hydroxiethyl)phenol as agonists of the beta2 adrenergic receptor
01/14/2009EP2013182A2 Aminoquinolones as gsk-3 inhibitors
01/14/2009EP1477472B1 Substituted phenylalkanoic acid derivative and use thereof
01/14/2009EP1317443B1 Chemokine receptor binding heterocyclic compounds
01/14/2009CN101346141A Quinoline derivatives useful in the treatment of MGLUR5 receptor-mediated disorders
01/14/2009CN100451004C Novel quinoline,Tetrahydroquinazoline,And pyrimidine derivatives and methods of treatment related to the use thereof
01/14/2009CN100450998C Urea derivative and process for producing the same
01/14/2009CN100450994C Adamantyl acetamides as 11-beta hydroxysteroid dehydrogenase inhibitors
01/14/2009CN100450485C 5-HT 1a receptor subtype agonists
01/13/2009US7476748 decyclization of {3-[(E)-2(7-chloro-2-quinolinyl)vinyl]phenyl}-4,5-dihydro-3H-benzo[c]thiepin-1-one by methylmagnesium halide with following conversion to montelukast
01/13/2009US7476686 e.g. 1-(Benzofuran-2-carbonyl-3-(3-phenoxy-phenyl)-thiourea; viricides; Hepatitis C infection
01/13/2009US7476680 e.g. 1-[2-hydroxy-3-(quinolin-5-yloxy)-propyl]-piperidine-4-carboxylic acid [4-phenyl-1-(3-phenyl-propyl)-butyl]-amide; multidrug resistance protein or P-glycoprotein modulator; with other therapeutic agent: anticarcinogenic, antibacterial, antiviral, antifungal agents
01/13/2009US7476675 Quinolinone derivatives and uses thereof
01/13/2009US7476673 4-[3-Hydroxyimino-3-(5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalen-2-yl)-propenyl]-benzoic acid; emphysema; respiratory system and skin disorder; acne and psoriasis; side effect reduction; improved pharmacology
01/08/2009WO2009006580A1 Optionally condensed dihydropyridine, dihydropyrimidine and dihydropyrane derivatives acting as late sodium channel blockers
01/08/2009WO2009005460A1 Small molecule inhibitors of navl.7 sodium channels for the treatment of pain disorders
01/08/2009WO2009003590A1 A process for the palladium-catalyzed coupling of terminal alkynes with heteroaryl tosylates and heteroaryl benzenesulfonates
01/08/2009US20090012074 Arylsulfonylmethyl or arylsulfonamide substituted aromatic compounds suitable for treating disorders that respond to modulation of the Dopamine D3 receptor
01/08/2009US20090012061 A Method of Treating Cancer
01/08/2009US20090012056 Quinoline Compounds Capable of Binding the Cb2 and/or the 5-Ht6 Receptor
01/08/2009US20090012055 Piperidine derivatives such as 4-{4-[3-(2-Methoxybenzyloxy)propoxy]phenyl}-3-[3-methoxy-5-(3-methoxypropoxy)benzyloxy]piperidine, suitable as renin inhibitors, used for the treatment of hypertension, heart failure, glaucoma, cardiac infarction, kidney failure or restenosis; improved pharmacokinetics
01/08/2009US20090011454 Fluorescent Sensors for Cellular Amines
01/08/2009US20090011024 Pharmaceutical compositions of dispersions of amorphous drugs mixed with polymers
01/08/2009CA2690679A1 A process for the palladium-catalyzed coupling of terminal alkynes with heteroaryl tosylates and heteroaryl benzenesulfonates
01/07/2009EP2010496A1 4-anilinoquinoline-3-carboxamides as csf-1r kinase inhibitors
01/07/2009EP2010479A1 11 beta-hydroxysteroid dehydrogenase type 1 active compounds
01/07/2009EP1569916B1 Substituted aralkyl derivatives
01/07/2009EP1431285B1 Reverse hydroxamic acid derivatives
01/07/2009CN101341126A Antibacterial active 5-chinolin derivative
01/07/2009CN101337940A Nitrogen heterocyclic ring dichlorin allyl ether compounds with insecticidal activity
01/07/2009CN101337934A Method for preparing fluoroquinolone compound
01/07/2009CN101337933A Crystal of salt of 4-(3-chloro-4-(cyclopropylaminocarbonyl)amino-phenoxy)-7-methoxy-6-quinolinecarboxamide or of solvate thereof and processes for producing these
01/07/2009CN101337932A Crystal of salt of 4-(3-chloro-4-(cyclopropylaminocarbonyl)amino-phenoxy)-7-methoxy-6-quinolinecarboxamide or of solvate thereof and processes for producing these
01/07/2009CN101337931A Crystal of salt of 4-(3-chloro-4-(cyclopropylaminocarbonyl)amino-phenoxy)-7-methoxy-6-quinolinecarboxamide or of solvate thereof and processes for producing these
01/07/2009CN101337930A Urea derivative and process for producing the same
01/07/2009CN101337929A Process for synthesizing quinclorac by oxidizing reaction
01/07/2009CN101337928A Quinoline compounds, synthesizing method, applications in synthesis of alkaloid of camptothecins
01/07/2009CN101337856A Method for preparing methyl ketone compounds with heterocyclic ring
01/07/2009CN100448905C High-polymer molecular hybrid luminescent materials containing 8-hydroxyquinoline metal complex and production thereof
01/07/2009CN100448853C Current carrier transmtiting material with high-effect and balancing electronic cavity transmitting performance
01/06/2009CA2421008C Substituted heterocyclic compounds for treating multidrug resistance
1 ... 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 ... 277